Donald TrumpBritain State travel With an announcement, the US firm would invest 150 billion pounds in the UK.
The US President’s tariff plans lead to a significant period for global trade, after creating significant trade tension earlier this year.
In some regions, firms have announced new commitments to pump billions in the UK, in a possible boost for Chancellor Rachel Reeves.
However, some industries criticized the business deal support and lack of difficult investment status in the UK.
Therefore, which sector winners and lost this week are:
Winners
Technology
Technology firms have been at the forefront of major investment deals in the UK.
On Wednesday, Prime Minister Sir Kir Stamor And Mr. Trump announced that a “technical prosperity deal” would see the UK and the US cooperating in areas including Artificial Intelligence (AI), quantum computing and nuclear power.
US top technology companies announced an investment of £ 31 billion along with the announcement.
These included a commitment by Microsoft to expand the UK’s AI infrastructure and invest £ 22 billion in the UK for the construction of the country’s largest AI supercomputer.
NVIDIA boss Jensen Huang received the title of “Bada Week for AI in the UK”, as the US chip giant committed to support the development of the supercomputer.
The firm agreed to deploy 120,000 advanced processors across the UK to help improve infrastructure in the British AI region.
Google invested £ 5 billion, focusing on research and development and improvement in AI infrastructure.
The AI Cloud Computing Company was also a part of small investments by technical companies including Korwaves, Salesforce and AI Pathfinder.
protect
The US software company Palantir announced a plan to invest £ 1.5 billion in the UK defense sector, which was funded in the development of artificial intelligence-powered capabilities to speed up decision making, military plan and targeting.
Defense Secretary John Heli said that investment was “the major vote of trust” for the UK.
Palauntir said that it plans to establish the UK as its European headquarters for defense, producing 350 “high-skilled” new jobs.
Manufacturing and R&D
There were many investments such as £ 3.9 billion from prologice to run an increase in life science and advanced manufacturing.
The US engineering firm Stax committed 37 million pounds to expand its operations and pioneer emission-less technology.
Infrastructure
Private equity giant Blackstone said it plans to invest in the UK property in the next decade, the biggest investment commitment.
This includes £ 10 billion of the already declared investment in its UK data centers.
Nuclear Engineering Company Amentum confirmed an investment of £ 150 million in the UK and said it plans to create more than 3,000 new jobs to increase its UK workforce over 50 percent over the next four years.
X-Energy and Centric also said that they are planning to construct 12 advanced modular reactors.
Loser
steel
The steel industry was one of the main areas to be disappointed with the President’s visit.
UK Steel Exports has been sheltered to spread plans for US tariffs, Britain has stopped its push to bring Levi to zero.
UK Steel exports to the US currently face 25 percent tariffs, while 50 percent for other countries.
Earlier this year, the UK and US agreed to give exemption from tariffs for UK Steel.
Gareth Stace, Director General of Industry Trade Association UK Steel, said it was “disappointing”.
Medicines
As part of investment among countries, UK pharmaceutical giant GSK revealed about £ 22 billion in US R&D and manufacturing plans in the next five years.
The government said the deal “will strengthen the UK-US life science relations” but it comes amidst a challenging background for investment for the field in the UK.
Last week, the US-based Merc said that its UK Operation would scrap plans for the £ 1 billion site in Kings Cross, which was about to open in 2027.
The owners blamed the government for making very little payments for drugs and not making enough investments in the area, as it confirmed the move that would affect about 125 jobs.
A few days later, Astrazheneka announced that it has stopped a plan to invest £ 200 million at the Cambridge research site in the latest major setback for the region.
Industry owners told MPs this week that the “difficult” environment and pressure on pricing in the UK had created a less attractive investment environment than other countries like the US.
Mr. Trump told reporters on Thursday that the drug firm was returning to America from other countries.
“Car companies are moving forward, AI is going in, everyone is coming in … pharmaceutical companies are coming back, they all want to be there – they want to stay there – but they all want to stay there.”